Kenneth Heym

1.4k total citations
26 papers, 366 citations indexed

About

Kenneth Heym is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Kenneth Heym has authored 26 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 8 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Kenneth Heym's work include Acute Myeloid Leukemia Research (8 papers), Acute Lymphoblastic Leukemia research (7 papers) and Histone Deacetylase Inhibitors Research (5 papers). Kenneth Heym is often cited by papers focused on Acute Myeloid Leukemia Research (8 papers), Acute Lymphoblastic Leukemia research (7 papers) and Histone Deacetylase Inhibitors Research (5 papers). Kenneth Heym collaborates with scholars based in United States, Australia and Switzerland. Kenneth Heym's co-authors include Hiroto Inaba, Raul C. Ribeiro, Ching‐Hon Pui, Jeffrey E. Rubnitz, Stanley Pounds, Elaine Coustan‐Smith, Dario Campana, Sharyn D. Baker, Deborah Schiff and Mihaela Onciu and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Kenneth Heym

24 papers receiving 362 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kenneth Heym United States 10 157 135 102 85 83 26 366
Pasquale Barbaro Australia 10 167 1.1× 124 0.9× 133 1.3× 126 1.5× 52 0.6× 25 453
Keiko Kagami Japan 11 129 0.8× 80 0.6× 130 1.3× 78 0.9× 83 1.0× 37 379
Bachar Samra United States 9 150 1.0× 136 1.0× 97 1.0× 52 0.6× 113 1.4× 18 364
Joanna Zawitkowska Poland 11 121 0.8× 115 0.9× 126 1.2× 45 0.5× 173 2.1× 61 386
Maoquan Qin China 10 137 0.9× 90 0.7× 55 0.5× 59 0.7× 45 0.5× 45 341
Frauke Bellos Germany 11 254 1.6× 98 0.7× 138 1.4× 53 0.6× 145 1.7× 21 428
G Prentice Australia 7 210 1.3× 103 0.8× 71 0.7× 85 1.0× 63 0.8× 13 387
Kathleen Glick United States 6 277 1.8× 132 1.0× 116 1.1× 33 0.4× 157 1.9× 9 377
Sajad Khazal United States 10 151 1.0× 138 1.0× 66 0.6× 42 0.5× 122 1.5× 33 322
Kun Soo Lee South Korea 12 287 1.8× 98 0.7× 70 0.7× 126 1.5× 43 0.5× 43 449

Countries citing papers authored by Kenneth Heym

Since Specialization
Citations

This map shows the geographic impact of Kenneth Heym's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth Heym with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth Heym more than expected).

Fields of papers citing papers by Kenneth Heym

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenneth Heym. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth Heym. The network helps show where Kenneth Heym may publish in the future.

Co-authorship network of co-authors of Kenneth Heym

This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth Heym. A scholar is included among the top collaborators of Kenneth Heym based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth Heym. Kenneth Heym is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ray, Anish, et al.. (2025). Life-threatening Lymphatic Malformation With Somatic Activating NRAS Mutation Successfully Treated With Trametinib: A Case Study. Journal of Pediatric Hematology/Oncology. 47(2). e104–e106.
2.
Wu, Huiyun, Xueyuan Cao, Abdelrahman H. Elsayed, et al.. (2024). Pharmacogenomic Score Effectively Personalizes Treatment of Acute Myeloid Leukemia. Clinical Cancer Research. 30(19). 4388–4396. 1 indexed citations
3.
4.
Brown, Austin L., Olga A. Taylor, M. Brooke Bernhardt, et al.. (2024). Evaluation of Methotrexate Pharmacogenomic Variants to Predict Acute Neurotoxicity in Children with Acute Lymphoblastic Leukemia. Blood. 144(Supplement 1). 4190–4190. 1 indexed citations
5.
Lamba, Jatinder K., Huiyun Wu, Xueyuan Cao, et al.. (2024). Pharmacogenomics, Race, and Treatment Outcome in Pediatric Acute Myeloid Leukemia. JAMA Network Open. 7(5). e2411726–e2411726. 2 indexed citations
6.
Lamba, Jatinder K., Huiyun Wu, Xueyuan Cao, et al.. (2023). Intensification of Therapy and Pharmacogenetic Personalization Mitigate Racial Disparities in Pediatric Acute Myeloid Leukemia Outcomes. Blood. 142(Supplement 1). 386–386. 1 indexed citations
7.
8.
Heym, Kenneth, Prakash Masand, & Judith Margolin. (2022). How we approach the diagnosis of a vascular anomaly. Pediatric Blood & Cancer. 69(S3). e29802–e29802. 2 indexed citations
9.
Heym, Kenneth, et al.. (2021). Multidisciplinary Multiagent Treatment of Complex Lymphatic Anomalies with Severe Bone Disease: A Single-Site Experience. Lymphatic Research and Biology. 20(2). 118–124. 2 indexed citations
10.
Nguyen, Rosa, Huiyun Wu, Stanley Pounds, et al.. (2019). A phase II clinical trial of adoptive transfer of haploidentical natural killer cells for consolidation therapy of pediatric acute myeloid leukemia. Journal for ImmunoTherapy of Cancer. 7(1). 81–81. 87 indexed citations
11.
Rubnitz, Jeffrey E., Norman J. Lacayo, Hiroto Inaba, et al.. (2019). Clofarabine Can Replace Anthracyclines and Etoposide in Remission Induction Therapy for Childhood Acute Myeloid Leukemia: The AML08 Multicenter, Randomized Phase III Trial. Journal of Clinical Oncology. 37(23). 2072–2081. 27 indexed citations
12.
Heym, Kenneth, et al.. (2017). Pleuropulmonary Blastoma: A Single-center Case Series of 6 Patients. Journal of Pediatric Hematology/Oncology. 39(8). e419–e422. 6 indexed citations
13.
14.
Basha, Riyaz, Nirupama Sabnis, Kenneth Heym, W. Paul Bowman, & Andras G. Lacko. (2014). Targeted Nanoparticles for Pediatric Leukemia Therapy. Frontiers in Oncology. 4. 101–101. 19 indexed citations
15.
Heym, Kenneth, et al.. (2014). Nonhematologic Toxicity of Imatinib Mesylate in Pediatric Patients With Chronic Myelogenous Leukemia. Journal of Pediatric Hematology/Oncology. 37(2). e111–e113. 2 indexed citations
16.
Peters, Tricia, Marie‐Luise Berres, Jeremy Price, et al.. (2013). Hematopoietic Stem Cells and Circulating Myelomonocytic Precursors With BRAF-V600E Are Identified In High-Risk Patients and Define LCH As a Myeloid Neoplasia. Blood. 122(21). 103–103. 1 indexed citations
17.
Thienprayoon, Rachel, et al.. (2013). Accidental Overdose of Intrathecal Cytarabine in Children. Annals of Pharmacotherapy. 47(5). e24–e24. 2 indexed citations
18.
Inaba, Hiroto, Jeffrey E. Rubnitz, Elaine Coustan‐Smith, et al.. (2011). Phase I Pharmacokinetic and Pharmacodynamic Study of the Multikinase Inhibitor Sorafenib in Combination With Clofarabine and Cytarabine in Pediatric Relapsed/Refractory Leukemia. Journal of Clinical Oncology. 29(24). 3293–3300. 121 indexed citations
19.
20.
Leen, Ann M., Aaron E. Foster, Kenneth Heym, et al.. (2006). Contact-activated Monocytes: Efficient Antigen Presenting Cells for the Stimulation of Antigen-specific T cells. Journal of Immunotherapy. 30(1). 96–107. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pasquale Barbaro Breakdown of academic impact, for papers by Keiko Kagami Breakdown of academic impact, for papers by Bachar Samra Breakdown of academic impact, for papers by Joanna Zawitkowska Breakdown of academic impact, for papers by Maoquan Qin Breakdown of academic impact, for papers by Frauke Bellos Breakdown of academic impact, for papers by G Prentice Breakdown of academic impact, for papers by Kathleen Glick Breakdown of academic impact, for papers by Sajad Khazal Breakdown of academic impact, for papers by Kun Soo Lee
Rankless by CCL
2026